Clinical Trial Update: Carboplatin, Paclitaxel, and Temozolomide for Patients With Metastatic Melanoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a combination of carboplatin, paclitaxel, and temozolomide in metastatic melanoma has been terminated, with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)
• Temozolomide (Temozolomide)

Snippet

Sponsor: New Mexico Cancer Research Alliance | Conditions: Melanoma | Phase 2 | Status: TERMINATED | Results posted: 2015-11-03